Traumatic Brain Injury Diagnostic Equipment Market Scope And Analysis

  • Report Code : TIPRE00018814
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 305
Buy Now

Traumatic Brain Injury Diagnostics Equipment Market Scope, Growth, Size and Share by 2030

Buy Now

Traumatic Brain Injury Diagnostics Equipment Market Report Traumatic Brain Injury Diagnostics Equipment Market Size and Share Traumatic Brain Injury Diagnostics Equipment Market Scope and Analysis

Traumatic Brain Injury Diagnostics Equipment Market Report Scope

Report Attribute Details
Market size in 2022 US$ 3.16 Billion
Market Size by 2030 US$ 7.87 Billion
Global CAGR (2022 - 2030) 12.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Technique
  • Noninvasive
  • Invasive
  • Combination Techniques
By Device Type
  • Imaging Devices and Monitoring Devices
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GE HealthCare Technologies Inc
  • Elekta AB
  • Integra LifeSciences Holdings Corp
  • Natus Medical Inc
  • Raumedic AG
  • BrainScope Co Inc
  • Luciole Medical AG
  • Soterix Medical Inc
  • Medtronic Plc

    • Industry Developments and Future Opportunities:

    The traumatic brain injury diagnostics equipment market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players operating in the market are listed below:

    • In October 2023, GE Healthcare Technologies Inc announced a collaboration with Imeka to expand the capabilities of MRI for brain imaging and further develop advanced precision medicine for brain health. Under the collaboration, GE Healthcare Technologies Inc has utilized Imeka’s neuroimaging technology, ANIE biomarker platform, which has broader applicabilities in research and clinical care settings across the spectrum of central nervous system diseases and disorders, such as traumatic brain injury, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The ANIE biomarker platform is integrated with artificial intelligence that identifies and quantifies axonal loss, neuroinflammation, and demyelination. Thus, with the collaboration, GE Healthcare Technologies Inc integrated its BrainWave advanced diffusion processing package with the ANIE biomarker platform. The newly integrated technologies have allowed researchers and clinicians to analyze diffusion MRI signals in the brain in greater detail.

    Competitive Landscape and Key Companies:

    Besides highlighting the factors impacting the market, the traumatic brain injury diagnostics equipment market report showcases the developments of prominent players. GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, and Neurovigil Inc are among the prominent companies operating in the market. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.